StonvexLoading…
StonvexStonvexStonvexCore line items from BRLS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2024 2024-12-31 | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 | Annual 2023 2023-12-31 |
|---|---|---|---|---|
Revenue | $29.10M | $22.04M | $13.96M | $31.38M |
Operating Income | $-20.40M | $-15.78M | $-12.16M | $-19.95M |
Net Income | $-25.33M | $-19.56M | $-6.30M | $-27.48M |
EPS (Diluted) | $-1.25 | $-0.98 | $0.77 | $-2.56 |
Total Assets | $60.01M | $61.91M | $63.59M | $65.79M |
Total Liabilities | $60.70M | $56.84M | $53.69M | $87.13M |
Cash & Equivalents | $652.97K | $721.54K | $3.13M | $7.62M |
Free Cash Flow OCF − CapEx | $-16.74M | $-15.79M | $-12.07M | $-22.47M |
Shares Outstanding | 21.38M | 19.95M | 19.23M | 10.75M |